<<
>>

DISEASE CONDITIONS ASSOCIATED WITH THE MAMMARY GLAND

22.17.1 Mastitis

Mastitis poses a significant challenge for dairy farmers globally, impacting milk production, animal well-being, and farm profitability. Let’s delve into the dynamics of mas­titis in cows:

1.

Causes: Mastitis in cows can arise from a multi­tude of factors, ranging from bacterial infections and subpar milking hygiene to unfavorable envi­ronmental conditions like unclean bedding or damp pastures. It can also stem from inadequate management of udder health and the spread of contagious pathogens through cow-to-cow contact or milking equipment.

2. Types: Within the bovine realm, mastitis mani­fests in two distinct forms: clinical and subclinical. Clinical mastitis presents visible signs of udder inflammation, including swelling, warmth, red­ness, and the presence of abnormal milk textures or discoloration. On the other hand, subclinical mastitis lurks beneath the surface, devoid of overt clinical indicators but detectable through labora­tory assessments like somatic cell count analysis.

3. Symptoms: Recognizable symptoms of clinical mastitis in cows encompass observable changes in the udder, such as swelling, warmth, or red­ness, alongside anomalies in milk consistency or appearance. Affected cows may also exhibit dis­comfort during milking, reduced milk output, or systemic signs of illness like fever or lethargy.

4. Diagnosis: Diagnosis of mastitis in cows involves a blend of astute clinical observation, meticulous udder examination, and precise laboratory scru­tiny of milk samples. Tests like the California Mastitis Test (CMT) or somatic cell count analysis

serve as pivotal diagnostic tools, particularly for uncovering subclinical cases.

5. Treatment: Managing mastitis in cows typically entails a tailored approach centered on antibiotic therapy targeted at the specific causative bacteria. In severe instances, supplementary measures such as anti-inflammatory medications or intramam­mary infusions may be warranted to alleviate dis­comfort and expedite recovery.

6. Prevention: Proactive measures to thwart mastitis in cows hinge on fostering optimal udder health and implementing sound management proto­cols. This entails upholding meticulous milking hygiene, vigilantly monitoring udder health, and promptly identifying mastitis cases. Furthermore, minimizing exposure to environmental pathogens through pristine housing and pastures, alongside strategic vaccination and genetic selection, are integral components of a comprehensive preven­tion strategy.

22.17.2 Neoplasia

Neoplasia, characterized by abnormal cell growth, was a concerning condition associated with the mammary gland in cows. Here’s an overview of mammary gland neoplasia in cows:

1. Types: Mammary gland neoplasia in cows could manifest as either benign or malignant tumors. Benign tumors, like adenomas or fibroadenomas, typically grew slowly and remain localized. In contrast, malignant tumors, including adenocar­cinomas or sarcomas, were more aggressive and could metastasize to other parts of the body.

2. Causes: The exact causes of mammary gland neoplasia in cows were not fully understood, but factors such as hormonal imbalances, genetic pre­disposition, and environmental factors might have played a role. Chronic inflammation and exposure to carcinogens in the environment or feed might also have contributed to the development of mam­mary tumors in cows.

3. Symptoms: Symptoms of mammary gland neopla­sia in cows could vary depending on the type and stage of the tumor. Common signs included:

• Palpable masses or lumps in the udder or mammary gland area

• Changes in udder size, shape, or texture

• Abnormalities in milk production, such as changes in milk yield or quality

• Pain or discomfort in the udder

• Ulceration or discharge from the udder

4. Diagnosis: Diagnosis of mammary gland neopla­sia in cows typically involved a combination of physical examination, imaging techniques (such as ultrasound or mammography), and biopsy of the affected tissue.

Laboratory analysis of tissue samples could help determine the nature of the tumor (benign or malignant) and guide treatment decisions.

5. Treatment: Treatment options for mammary gland neoplasia in cows might have varied depending on the type, size, and stage of the tumor, as well as the overall health of the cow. Treatment might have included surgical removal of the tumor, che­motherapy, radiation therapy, or supportive care to manage symptoms and improve quality of life.

6. Prognosis: The prognosis for cows with mammary gland neoplasia depended on factors such as the type and stage of the tumor, response to treat­ment, and overall health of the cow. Early detec­tion and prompt intervention could have improved the chances of successful treatment and long-term survival.

22.17.3 Hypocalcemia

Hypocalcemia, commonly referred to as milk fever, was a significant disease condition associated with the mammary gland in cows. Here’s an overview of cow hypocalcemia:

1. Definition: Hypocalcemia referred to low levels of calcium in the blood, which could lead to various health issues in cows, including those related to the mammary gland.

2. Causes: The primary cause of hypocalcemia in cows was the sudden demand for calcium during the onset of lactation. This demand often exceeded the cow’s ability to mobilize calcium from its bones or absorb it from the diet, leading to a defi­ciency. Factors such as inadequate dietary calcium intake, improper feeding management, breed pre­disposition (e.g., high-producing dairy breeds), and hormonal imbalances could contribute to the development of hypocalcemia.

3. Symptoms: Symptoms of hypocalcemia in cows could include: muscle weakness or tremors, stiff gait or difficulty walking, reduced milk produc­tion, loss of appetite, lethargy or depression, ster­nal or lateral recumbency (in severe cases)

4. Diagnosis: Diagnosis of hypocalcemia in cows was based on clinical signs and could be con­firmed through blood tests to measure serum calcium levels.

Additionally, veterinarians could evaluate other blood parameters such as magne­sium and phosphorus levels to rule out concurrent metabolic disorders.

5. Treatment: Treatment of hypocalcemia in cows typically involved intravenous administration of calcium solutions to rapidly increase blood cal­cium levels. Additionally, oral calcium supple­ments might have been provided to maintain calcium levels in the long term. In severe cases, supportive care such as fluid therapy and manage­ment of secondary complications might have been necessary.

6. Prevention: Prevention of hypocalcemia in cows focused on optimizing dietary calcium intake, particularly during the transition period from late pregnancy to early lactation when calcium demands were highest. Strategies included feeding high-calcium diets, providing access to mineral supplements, and implementing proper manage­ment practices to reduce stress and maintain cow health during this critical period.

22.17.4 Puerperal Tetany or Eclampsia

Puerperal tetany, also referred to as eclampsia or hypocal­cemia, a critical condition associated with the mammary gland in cows, particularly during the postpartum period. Here’s an overview:

1. Definition: Puerperal tetany, or eclampsia, a meta­bolic disorder characterized by low blood calcium levels, primarily occurring in cows shortly after calving or during early lactation. This condition could have severe consequences for both the cow and her offspring if left untreated.

2. Causes: The main cause of puerperal tetany in cows was the sudden increase in calcium demand during the onset of lactation, which exceeded the cow’s ability to mobilize calcium reserves or absorb calcium from the diet. This imbalance could lead to hypocalcemia and subsequent clini­cal signs of tetany.

3. Symptoms: Clinical signs of puerperal tetany in cows could include: muscle tremors or spasms, stiff gait or difficulty walking, hyperesthesia (increased sensitivity to touch), fever, restlessness or agitation, and in severe cases, convulsions or seizures might have occurred.

4. Diagnosis: Diagnosis of puerperal tetany in cows was typically based on clinical signs and could be confirmed through blood tests to measure serum calcium levels. Additionally, veterinarians might have evaluated other blood parameters to rule out concurrent metabolic disorders.

5. Treatment: Treatment of puerperal tetany in cows involved immediate correction of calcium levels. This often required intravenous administration of calcium solutions to rapidly increase blood calcium levels. Additionally, oral calcium supple­ments might have been provided to maintain cal­cium levels in the long term. Supportive care, such as fluid therapy and management of secondary complications, might also have been necessary.

6. Prevention: Prevention of puerperal tetany in cows focused on optimizing dietary calcium intake during late pregnancy and early lactation. This included feeding high-calcium diets and provid­ing access to mineral supplements. Proper man­agement practices, such as minimizing stress and ensuring adequate nutrition during the transi­tion period, were also crucial in preventing this condition.

Puerperal tetany was a serious condition that required prompt recognition and intervention to prevent complica­tions and ensure the health and productivity of the cow and her offspring.

22.18

<< | >>
Source: Rana Tanmoy (ed.). Principles of Veterinary Animal Physiology. CRC Press,2026. — 290 p.. 2026

More on the topic DISEASE CONDITIONS ASSOCIATED WITH THE MAMMARY GLAND: